Lund University, Department of Occupational and Environmental Dermatology, Skåne University Hospital, Malmö, Sweden.
Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Contact Dermatitis. 2021 May;84(5):326-331. doi: 10.1111/cod.13728. Epub 2020 Dec 1.
Polyaminopropyl biguanide (INCI name) and polyhexamethylene biguanide (PHMB) are polymeric biguanides. PHMB is a broad-spectrum antimicrobial substance used as a preservative in many products. Due to our limited knowledge on PHMB contact allergy frequency and the fact that cases of allergic contact dermatitis to PHMB might be missed, we have included PHMB as a screening allergen since 2016.
To report the prevalence of positive patch test reactions to PHMB as a screening allergen in patients with suspected allergic contact dermatitis.
A retrospective analysis of 1760 patch tested patients from July 2016 to December 2018 was performed. Polyaminopropyl biguanide 2.0% aqua was included in the extended Malmö baseline series during the study period.
Of all patients, 1204 (68.4%) were female. Positive patch test reactions were reported in 19 patients (1.1%). The most common sites of lesions were face, head, and neck (52.6%). There was a significant correlation between concomitant reactions to PHMB and other cosmetic-related allergens.
The prevalence of positive reactions to PHMB was higher than that previously reported. Patch testing with PHMB should be performed in patients with dermatitis who have lesions on the face, head, and neck.
聚六亚甲基双胍(INCI 名称)和聚亚氨基丙基双胍(PHMB)是聚合双胍。PHMB 是一种广谱抗菌物质,用作许多产品的防腐剂。由于我们对 PHMB 接触过敏频率的了解有限,并且可能会错过 PHMB 过敏接触性皮炎的病例,因此自 2016 年以来,我们已将 PHMB 纳入筛查变应原。
报告疑似过敏性接触性皮炎患者中 PHMB 作为筛查变应原的阳性斑贴试验反应的流行率。
对 2016 年 7 月至 2018 年 12 月期间进行的 1760 例斑贴试验患者进行回顾性分析。在研究期间,聚亚氨基丙基双胍 2.0%水合物被纳入扩展的马尔默基础系列。
所有患者中,1204 例(68.4%)为女性。19 例(1.1%)报告阳性斑贴试验反应。病变最常见的部位是面部、头部和颈部(52.6%)。PHMB 与其他与化妆品相关的变应原同时发生反应与显著相关。
对 PHMB 的阳性反应率高于以往报道。对于面部、头部和颈部有病变的皮炎患者,应进行 PHMB 斑贴试验。